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Abstract
Background: Urtica dioica (UD) has been identified as a traditional herbal medicine. This study aimed to investigate
the effect of UD extract and swimming activity on diabetic parameters through in vivo and in vitro experiments.
Methods: Adult WKY male rats were randomly distributed in nine groups: intact control, diabetic control,
diabetic + 625 mg/kg, 1.25 g/kg UD, diabetic + 100 mg/kg Metformin, diabetic + swimming, diabetic + swimming
625 mg/kg, 1.25 g/kg UD, and diabetic +100 mg/kg Metformin + swimming. The hearts of the animals were
punctured, and blood samples were collected for biochemical analysis. The entire pancreas was exposed for
histologic examination. The effect of UD on insulin secretion by RIN-5F cells in 6.25 or 12.5 mM glucose dose
was examined. Glucose uptake by cultured L6 myotubes was determined.
Results: The serum glucose concentration decreased, the insulin resistance and insulin sensitivity significantly
increased in treated groups. These changes were more pronounced in the group that received UD extract
and swimming training. Regeneration and less beta cell damage of Langerhans islets were observed in the
treated groups. UD treatment increased insulin secretion in the RIN-5F cells and glucose uptake in the L6
myotubes cells.
Conclusions: Swimming exercises accompanied by consuming UD aqueous extracts effectively improved
diabetic parameters, repaired pancreatic tissues in streptozotocin-induced diabetics in vivo, and increased
glucose uptake or insulin in UD-treated cells in vitro.
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Background
Diabetes mellitus is one of the most common metabolic
diseases caused by high blood glucose and lack of insulin
production or sensitivity, which influence body system
functions [1]. Insulin resistance syndrome is one of the
metabolic dysfunctions that play a crucial role in the
pathogenesis of type 2 diabetes mellitus [2, 3]. Obesity
and high triglyceride (TG) levels are dependent risk fac-
tors for insulin resistance syndrome [4, 5]. The increase
in the number of people afflicted with diabetes over the
past two decades can be due to lessened physical
activity, poor dietary habits, overweight or obesity, and
psychological stress [6, 7]. Diabetes is an epidemic
disease, and over 5 % of the total population or an
estimated 135 million people are infected. Hence, the
World Health Organization estimated a rising preva-
lence of this silent disease. Approximately 285 million
people worldwide were infected in 2010 [8], and this
number would likely reach about 380 million by 2025
[7], and 439 million by 2035 (7.7 %) [9–11]. These pre-
dictions estimate a growing burden of diabetes particu-
larly in developing countries [10]. This silent disease will
become the strongest and deadliest leading cause of
death in humans worldwide in the next 25 years [6].
Diabetes in populated countries such as India, China, and
United States is rapidly increasing. In India, 30 million
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people were diagnosed as diabetics in 1995, and by 2025,
this number is estimated to reach 70 million [11, 12].
Medicinal plants have been identified globally as bio-
logical source and have been investigated extensively as
crude material for treating various disease conditions be-
cause of their effectiveness and economic values. Plant-
derived medicines are safer to use than their synthetic
alternatives, offering profound therapeutic benefits and
affordable treatments. Currently, more than 30 % of
medicines derived from natural sources are used in hos-
pitals and clinics [13–15]. Despite their useful roles,
most of the chemical medicines used in diabetes have
damaging side effects [14, 16]; therefore, practitioners
have considered changing to alternative natural plant
therapy [17, 18]. Urtica dioica (UD) is one of natural
plants used in traditional medicine [19, 20]. It has been
used for homeopathy allergies, anemia, internal bleeding,
kidney stones, burns, and diabetes [21]. Aside from its
antihyperglycemic, anti-proliferative [22], anti-oxidant
[23], and anti-dandruff [24] properties, it has anti-
inflammatory or antimicrobial activity and has been
proven to cure infectious diseases [25]. Furthermore The
effects of UD on glucose transporter-4 (GLUT4) trans-
location on L6 muscle cells show that this plant stimu-
lates GLUT4 transport to plasma membrane and
glucose uptake into skeletal muscle [26].
The chemical compounds of this plant are lectin, leci-
thin, potassium, calcium, acetophenone, acetylcholine,
quercetin, quinic acid, chlorogenic acid, butyric acid, caf-
feic acid, carbonic acid, coumaric acid, formic acid, his-
tamine, succinic acid, pantothenic acid, linolenic acids,
palmitic acid, serotonin, stigmasterol, terpenes, choline,
agglutinin, alkaloids, xanthophyll, chlorophyll, kaemp-
ferol, coproporphyrin, lignan, linoleic, and violaxanthin.
UD also contains protein, fatty substance, albumins,
carotene, vitamin C, oxalate, fixed oil in its seeds, pro-
vitamin A, vitamin B1, K, xanthophylls, silicium, ferric
oxide, and sistosterin in its leaves [27–29]. Among the
many different types of this plant, two-basis nettle
(Urtica dioica L) has been known as a traditional medi-
cine in the world [27]. Other positive effects of this plant
are joint pain reduction, bone inflammation treatment
[30], cure for urinary tract infectious diseases, coronary
heart disease, diabetes, cancer, inflammation, psychotic
disorders, liver inflammation, and viral and parasitic dis-
eases [31, 32], as well as influences on physiological
brain function with exercise [33].
Aerobic activity is one of the useful ways to cure or
prevent diabetes [5, 7, 34]. Physical activity has associ-
ated effects on glycemic and lipid profiles as well as
metabolic risk factors for cardiovascular diseases, such
as reduction of insulin resistance, atherogenic lipid ab-
normalities, high blood pressure, and improvement of
metabolic status [34, 35]. The effect of regular exercise
on improving glucose metabolism is well known in type
2 diabetes [35, 36], which may be due, in part, to the
muscle contraction with insulin-like action as well as
training-induced adaptations [37, 38]. Both physical ac-
tivity and UD extract consumption approaches result in
hypoglycemia and hypolipidemia. Nevertheless, data on
the effect of the combination of these two beneficial var-
iables on diabetes are unavailable. To fill this research
gap, the present study aims to investigate in vivo and in
vitro evaluation of Urtica dioica effects and swimming
activity on diabetic factors and pancreatic beta cells on
streptozotocin diabetic with the use of synthetic metfor-
min medicine and normal rats.
Methods
Collection and preparation of plant samples
UD leaves were collected before the flowering season
from Saral mountainous rangelands of the Zagros
Mountains in Tabriz Khatoon Village of Kordestan
region (Iran). Samples were taken, identified, authenti-
cated, and deposited at Herbarium of Biochemistry
Department, university Malaya by agricultural expert
with voucher specimen no (19–5792).
Preparation of plant material aqueous extract
The UD leaves (6 kg) were rapidly washed, shade-dried
for 7 days, and then grounded to powder using an elec-
tric mill. To prepare aqueous extract, 1000 g of pow-
dered samples was infused using 90 % ethanol at a ratio
of 1 to 10. The eluate solution was fully concentrated
using rotary evaporator (K-1Karwerke, GMBH Sco KG,
Germany, TYP: Rvo6-ML, 010388949) at 75 °C to omit
the solution value. To prepare dry powder, the resulting
material was put in the oven for four days at 37 °C.
The final weight of the extracted matter was 60 g.
The extract sample was mixed with distilled water
and administered orally on daily basis doses of 1.25
and 0.625 (mg/kg/day) [39].
Gas chromatography/mass spectrometry (GC-MS) analysis
The chemical components of UD were determined by
using the HPLC method. A 10 μl aliquot of filtrate sam-
ple was injected into LC-A6 (Shimadzu Co., Japan),
equipped with a C18 column (Phenomenex Luna,
4.6 mm × 250 mm i.d., 5 μm) with mobile phase of
water/acetonitrile 3/7 v/v. The main components of UD
are presented in Table 1 and the chromatogram graphs
of total ions in standard solution are shown in Fig. 1.
In vitro studies
Cell culture
Rat pancreatic beta cell line (RIN-5F) and rat L6 myo-
blast cell line (L6) were used in this study. RIN-5 F and
L6 cells were purchased from the American Type
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Culture Collection (ATCC, USA). L6 cells (ATCC, CRL-
1458) were grown in Dulbecco’s Modified Eagle Medium
(DMEM, Life Technologies, Inc., Rockville, MD, USA)
and RIN-5 F (ATCC, CRL- 2058) cells were cultured in
RPMI-1640 (Sigma–Aldrich, St. Louis, MO, USA). The
cells were supplemented with 10 % fetal bovine serum
(FBS, Sigma–Aldrich, St. Louis, MO, USA) and 1 % anti-
biotics (100 IU/mL of penicillin and 100 μg/mL of
streptomycin (iDNA, South America) and were main-
tained in a humidified 5 % CO2 incubator at 37 °C.
Cells were seeded in a flask at the required density
per well and incubated for the desired time prior to
the experiments.
Cell viability assay
The influence of UD extract on RIN-5F and L6 cells was
evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay. For this pur-
pose, cells were seeded in a 96-well plate at density of
5 × 103 cells/well with 1 mL of culture medium. After
24 h incubation at 37 °C in 5 % CO2, culture media were
replaced by new media containing different concen-
trations (0, 0.375, 0.75, 1.5, 3, and 5 mg/mL) of UD
extracts. UD extracts were prepared and transferred
to the cells in the 96-well plate and incubated for an
additional 48 h. After a specified period, the medium
was discarded, and adherent cells were washed with
phosphate buffer solution (PBS). About 20 μL of
MTT solution (5 mg/mL MTT bromide in PBS) was
added, and the mixture was incubated for 4 h at 37 °C.
The medium was then removed, and the MTT formazan
crystals formed by the metabolically viable cells were
dissolved in 100 μL of dimethyl sulfoxide. Absorbance
Table 1 Content of UD components in the mass spectra
examined by HPLC
Peak # RRt Name of compound %
1 3.82 Propylene Glycol 2.30
2 4.01 Diethylene Glycol = DEG = Digol 2.19
3 4.30 1, 8-Cineole = Eucalyptol 10.40
4 6.49 Ethyl Benzoate 2.96
5 14.35 Gamma-Dodecalactone = 4-octylbutane-4-olide 1.11
6 16.82 Di iso-Butyl Phthalate 3.01
7 17.94 Palmitic Acid 3.30
8 18.20 Dibenzosuberone 1.47
9 18.30 Ethyl Palmitate 1.39
10 18.61 4-methyl-2, 6-di-t-butyl Phenol = BHT 1.66
11 19.56 Methyl Oleate 2.04
12 20.22 Stearic acid 1.31
13 20.59 Ethyl Stearate 1.19
14 21.70 Tricosane 1.29
15 24.25 Di-(2-ethylhexyl) Phthalate = DEHP = DOP 40.07
100
Fig. 1 Chromatogram showing total ions of fiftheen herbicides and degradation products in standard solution
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was measured at 595 nm. The assay was performed
in triplicate.
Insulin secretion by the cultured RIN-5 F pancreatic cell
RIN-5F cells were seeded in 24-well plates at 2 × 105
cells/well and incubated at 37 °C and 5 % CO2. After in-
cubation for 24 h, the medium was removed from the
wells, and the cells were washed twice with fresh
medium containing low glucose (6.25 mM) or high glu-
cose (12.5 mM). Afterward, the cells were incubated at
37 °C for 3 h with low glucose or high glucose medium,
supplemented with 1 % FBS and treated with low or
high concentrations of UD (1.5 and 3 mg/mL). Then,
the aliquots in all wells were collected to determine the
concentration of insulin in the media with the use of
ELISA kit (Insulin ELISA kit, Ab100578, Abcam, Cam-
bridge, UK) according to the manufacturer’s instructions.
The insulin secretion levels at different concentrations
of saffron were assessed by comparing them with the
control insulin secretion level. The 0 concentration of
extract (untreated cell) was considered as the control.
The experiment was conducted in triplicate, and the
data were presented as mean ± SD.
Determination of glucose uptake by cultured L6 myotubes
L6 myoblasts cells were subcultured in 24-well plates at
5 × 104 cells/well and allowed to proliferate for 11 days
to form myotubes in 0.4 mL of 10 % FBS/DMEM. The
medium was refreshed every 3 days. The 11-day-old
myotubes were kept for 2 h in Krebs–Henseleit buffer
(pH 7.4, 0.141 g/L of MgSO4, 0.16 g/L of KH2PO4,
0.35 g/L of KCl, 6.9 g/L of NaCl, 0.373 g/L of CaCl2-
2H2O, and 2.1 g/L of NaHCO3) containing 0.1 % bovine
serum albumin, 10 mM Hepes, and 2 mM sodium pyru-
vate (KHH buffer). The myotubes were thereafter
cultured in KHH buffer containing glucose (normal:
11 mM; high glucose: 25 mM) without or with UD ex-
tract (0, 1.5, and 3 mg/mL) for another 4 h. Glucose
concentrations in the KHH buffer were determined with
a glucose assay kit and a microplate reader (Appliskan,
Thermo Fisher Scientific Inc., Waltham, MA, USA) at
508 nm, and the consumed glucose levels were derived
from the differences in glucose concentrations between,
before, and after culturing [40].
In vivo studies
Animal
A total of 56 adult WKY (Wistar Kyoto) male rats (8–10
weeks of age, 253 ± 16 g of weight) were obtained from
the Animal Center, Bushehr University of Medical
Sciences and were caged under well ventilation in a
standard environment (12 h light:dark cycle). The ani-
mals had free access to soy-free diet (Gold Coin Pellet)
and tap water ad libitum. All procedures involving
animal experiments were approved and conducted in
strict accordance with the United States Institute of
Animal Research guidelines for the care and use of
laboratory animals [41] and approved by the Animal
Care and Use Committee University Malaya Institutional
with ethics number FIS/22/11/2011/FD(R). Blood sam-
pling was performed at a specified time (8:10 a.m.) when
the rats had had fasted at least 12 h. The animals were
randomly divided into nine groups: intact control (C),
diabetic control (CD), diabetic + 625 mg/kg UD (CD+
625 UD), diabetic + 1.25 g/kg UD (CD + 1.25 UD),
diabetic + 100 mg/kg Metformin (CD +M), diabetic +
swimming (CD + E), diabetic + swimming + 625 mg/kg
UD (CD + E + 625 UD), diabetic + swimming + 1.25 g/kg
UD (CD + E + 1.25 UD), and diabetic + 100 mg/kg
Metformin + swimming (CD + E +M). Six rats were
used in each group. The hearts of the animals were
punctured [42] after 4 weeks of swimming and UD
feeding process. Blood samples were collected to investi-
gate insulin, lipid, and lipoprotein indices. Whole pancreas
tissue was exposed for histologic examination.
Induction of experimental diabetes
To induce diabetes in rats, Streptozotocin (STZ, Enzo
Life Sciences) was used by intraperitoneal injection
(50 mg/kg). Distilled normal physiologic saline was used
to prepare the injection solution. Rats were fasted 14 h
before injection. The control group received normal
saline. Blood sample for glucose measurements was
collected from tail vein. A glucometer (Bionine-GM300)
was used to measure blood glucose. Hyperglycemic ani-
mals with fasting blood glucose of more than 250 mg/dl
were considered as diabetic.
Insulin resistance was calculated by following for-
mula [43]:
Insulin resistance ¼ fasting insulin μU=mLð Þ
 fasting glucose mg=dlð Þ=405
Serum insulin level was evaluated by ultra-sensitive rat
insulin ELISA Kit (Alpco-US). Insulin sensitivity was cal-
culated by following formula [44]:
1= log fasting insulin mU=Lð Þ þ log fasting glucose mg=dLð Þ½ 
The Friedewald equation method was used to meas-
ure low-density lipoprotein (LDL) cholesterol concen-
tration [45]. All data analyses were conducted in
triplicate.
Swimming protocol instructions
A swimming program was considered an exercise activity
model in this study. Swimming was conducted in a clear
plastic tank (70 cm× 90 cm× 150 cm) containing 30 cm
of water (28 ± 0.5 °C). Before the exercise program, the
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swimming groups were familiarized to swimming (5 min/
day in the first 3 days and 10 min/day in the second
3 days) to reduce stress. The exercise program con-
sisted of swimming five times per week with gradual
increases up to 4 weeks. The first week was for
15 min to 20 min at a depth of 20 cm; the second
week was for 20 min to 30 min at a depth of 30 cm;
the third week was for 30 min to 40 min at a depth
of 40 cm; and the fourth week was for 45 min at a
depth of 50 cm. the intensity of the exercise was
monitored by increasing time and depth of water in
plastic tank [39].
Histological experiment sample preparation
After 4 weeks of tests, the hearts of the animals were
punctured, and their pancreas tissues were exposed
for histological experiment. The tissue was cleaned,
fixed in 10 % formalin, and then paraffin embedded
for microscopic procedures. Histopathology test was
performed in hematoxylin and eosin stained at 5 μm
thickness (Leitz 1512, Germany). The cellularity evalu-
ation of Langerhans islets was conducted by light micro-
scope (BX41 Olympus).
Statistical analysis
All data values were mean ± standard deviation. The
obtained data in this study were analyzed using SPSS
version 17 and described in terms of central tendency
and dispersion. Analysis of variance was used to
evaluate the differences between the mean values.
Kolmogorov–Smirinov test showed that the data were
normally distributed. p value less than 0.05 was con-
sidered statistically significant.
Results
Cell proliferation assay
To assess the non-cytotoxic concentration of UD, the
viability of RIN-5F and L6 cells were evaluated at doses
ranging between 0 and 5 mg/mL using MTT assay.
Within the tested concentrations, UD showed negligible
cytotoxicity at 3–5 mg/mL in both tested cell lines (data
not shown), and concentrations up to 3 mg/mL of UD
were used in subsequent experiments.
Determination of insulin secretion by cultured RIN-5 F
pancreatic cells
As shown in Fig. 2, UD extract markedly increased the
insulin secretion in both treated doses at glucose con-
centrations of 6.25 mm, and 12.5 mm significant induc-
tion of insulin secretion was observed in the RIN-5F
cells treated with UD extract treatments.
Glucose uptake by cultured L6 myotubes
Differentiated L6 myotube cells were treated with UD to
determine the function of UD in glucose metabolism of
muscle cells, and their glucose uptakes were measured.
As shown in Fig. 3, the glucose uptake of myotubes was
considerably stimulated by the treatment of UD in a
concentration-dependent manner at concentrations of
1.5 and 3 mg/mL under normal glucose (11.1 mM) and
high glucose (25 mM) conditions. This result suggested
that UD may act on proteins associated with glucose
uptake signaling pathways in muscle cells.
Biochemical parameter results
The effect of UD aqueous extract and exercise on weight
loss in the control and administrated groups is shown in
Table 2. Substantial weight loss was observed in diabetic
Fig. 2 Effect of UD extract on glucose stimulated insulin release in RIN5 cells. Data were expressed as mean ± SD for 6 replicates. LD; low dose of
UD-treated (1.5 mg/ml), HD; high dose of UD-treated (3 mg/ml). *P value less than 0.05 considered as significant comparing low dose and high
dose of UD extract with untreated
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groups. After 4 weeks of exercise activities, UD and met-
formin caused significant changes in the average weight.
Weight gain was not significant in the treated groups;
however, among treated diabetic groups, the group
treated with UD dose of 1.25 g/kg with swimming activ-
ity had significant increase in weight compared with the
diabetic control group (p < 0.05).
The results indicated that blood glucose in the treated
groups had significant decrease compared with the dia-
betic control group (p < 0.05). Maximum reduction was
observed in the diabetic group administrated with
1.25 g/kg UD with swimming activity compared with the
diabetic control group (p < 0.000) and other groups
(p < 0.031). The blood glucose levels of all groups are
presented in Table 3.
The insulin resistance level was 11.68 in the diabetic
control group and 3.36 in the negative control. Homeo-
stasis Model Assessment-Insulin Resistance (HOMA.IR)
significantly decreased in the diabetic-treated groups
compared with diabetic control after 4 weeks of admin-
istration (p < 0.000). The HOMA.IR value in the diabetic
group treated with UD 1.25 g/kg and swimming was
2.16 and was 3.53 for the diabetic group without UD
treatment. These groups showed maximum decrease of
insulin resistance (p < 0.000 and p < 0.013, respectively).
The results of insulin resistance are shown in Table 3.
Swimming program in combination with aqueous ex-
tract of UD treatment and metformin consumption in
diabetic groups caused an increase in insulin sensitivity,
insulin serum level, and pancreatic function index com-
pared with the diabetic control group (p < 0.000). Insulin
sensitivity increase was more pronounced in both nega-
tive and diabetic control groups, which were treated
with UD 1.25 g/kg alongside swimming. No significant
difference in insulin serum concentration was observed
in the study groups (p > 0.05). Furthermore, the pancre-
atic function index in the treated group showed a signifi-
cant increase compared with the non-treated diabetic
group (p < 0.00), whereas maximum increase was ob-
served in the group treated with UD extract dose of
1.25 g/kg (p > 0.05). The glycemic index results are pre-
sented in Table 3.
The results in Table 4 show a significant decrease in
TG concentration of treated group compared with the
diabetic control group (p < 0.00), reaching a value close
to the level of the control group (p < 0.05). Maximum
reduction in TG levels was observed in diabetics swim-
ming (CD + E) and diabetics swimming + UD 1.25 g/kg
(CD +UD 1.25 + E) groups (i.e., 24 and 28 mg/dl, re-
spectively) (p < 0.05).
A significant decrease in the cholesterol concentra-
tion of diabetic + swimming (CD + E) and diabetic +
swimming + UD 1.25 g/kg (CD + UD 1.25 + E) groups
was observed compared with the diabetic control (CD)
and control groups (C) (p < 0.001). No significant changes
were observed in the other treated groups (p > 0.05). The
investigation of LDL and HDL levels showed that the
4-week exercise program, UD administration, and met-
formin had no significant effects on treated groups
(p > 0.05). The results of serum lipid and lipoprotein
are presented in Table 4.
Histological results
The administration of UD reduced the cellularity of the
pancreatic islet beta cells compared with the diabetic
control group. Significant increase in cellularity of islet
and regeneration was observed in both groups, which
received low dose and high dose of UD (Fig. 4a–d).
Fig. 3 Effect of UD extract on glucose uptake in L6 myotubes. Data were expressed as mean ± SD for 6 replicates. LD; low dose of UD-treated
(1.5 mg/ml), HD; high dose of UD-treated (3 mg/ml). *P value less than 0.05 considered as significant comparing low dose and high dose of UD
extract with untreated
Ranjbari et al. BMC Complementary and Alternative Medicine  (2016) 16:101 Page 6 of 11
Table 2 Comparison of the effect of UD and exercise on changes in rat’s weight
Intact control Diabetic control Diabetic +
625 mg/kg UD
Diabetic +
1.25 g/kg UD
Diabetic +
Metformin
Diabetic +
swimming
Diabetic + swimming +
625 mg/kg UD
Diabetic + swimming +
1.25 g/kg UD
Diabetic + Metformin +
swimming
Week 1 day 7 83/256 ± 22/25 246 ± 64/17 14/217 ± 15/44 219 ± 02/32 5/225 ± 28/28 7/206 ± 15/38 20/207 ± 89/43 203 ± 60/34 70/223 ± 41/34
Week 2 day 14 17/261 ± 8/24 05/235 ± 99/15 57/216 ± 57/44 43/220 ± 77/31 228 ± 45/27 2/205 ± 53/37 4/209 ± 41/45 5/207 ± 1/34 228 ± 97/32
Week 13 day 21 2/271 ± 64/25 09/229 ± 86/13 79/217 ± 85/41 5/221 ± 61/34 8/231 ± 79/26 209 ± 83/37 4/215 ± 24/45 33/218 ± 51/33 6/234 ± 11/32
Week 4 day 28 52/276 ± 63/28 08/227 ± 29/14 79/220 ± 28/38 36/228 ± 07/35 98/237 ± 94/27 8/209 ± 21/37 4/223 ± 36/43 42/226 ± 97/34 7/241 ± 94/29
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Discussion
Our in vivo study results revealed that the 4-week ad-
ministration of different doses of UD with exercises
on diabetic rats caused significant decrease in diabetes
markers, such as insulin resistance reduction, in-
creased insulin sensitivity, lower TG and cholesterol,
and improved function of the pancreatic beta cells
compared with the diabetic group. Improved weight
gain was noticed in the treatment groups. This posi-
tive change was more pronounced in the group that
had swimming activity and consumed 1.25 g/kg UD.
Increasing the enzyme hormone-sensitive lipase activ-
ity and stored triglycerides hydrolysis can release large
amounts of fatty acids and glycerol into the blood cir-
culation of patients with insulin deficient activity [46].
Thus, medications such as metformin that reduce
blood triglycerides and cholesterol did not signifi-
cantly change the lipid profiles, as observed in the
present study. The data from the in vitro study indi-
cated that UD extract increased insulin secretion
through RIN-5F and glucose uptake by the L6 myo-
tube cells.
The effects of UD on hypoglycemic, hypolipidemic,
protection, and beta cell regeneration have been proven
[15, 47] in several studies. Whereas Other studies have
indicated that UD consumption has no effect on blood
glucose and beta cell regeneration in diabetic rats [48].
By contrast, UD leaf extracts have been reported to have
a protective role in increasing blood glucose and
destroying pancreatic beta cells [19, 49]. Domola et al.
[50] concluded that the compound Gazlin from UD
extract has insulin-like effect in lowering blood glucose
in diabetic patients. These differences in results may be
caused by differences in regions, cities, and parts of UD
(stalk, root, and leaves) used.
Our result supports the findings of Silevera et al.
(2008), that is, blood sugar is reduced and weight is
induced in diabetic rats with swimming activity [51].
The present data were consistent with the findings of
Zinman et al. (2004) and confirmed the effect of exercise
on blood sugar and insulin resistance [52]. Tjønna et al.
[53] compared the effects of 90 % and 70 % aerobic exer-
cise intensity on metabolic factors and insulin sensitivity
in metabolic syndrome patients. Their data showed no
Table 3 The glycemic index result of study groups
Groups Glucose concentration Insulin concentration Insulin resistance Insulin sensitivity
C 108.5 ± 24.46a 13.05 ± 3.04 3.36 ± 0.48a 0.31 ± 0.01a
CD 467.16 ± 109.94 11.4 ± 3.53 11.68 ± 2.63 0.27 ± 0.01
CD + 0.625 UD 145.42 ± 14.16a 12.92 ± 2.37a 4.46 ± 0.26a 0.3 ± 0.006a
CD + 1.25 UD 158.28 ± 55.42a 15.24 ± 4.04a 5.54 ± 1.1a 0.29 ± 0.01a
CD +M 151.4 ± 30.55a 10.61 ± 1.18 3.89 ± 0.54a 0.31 ± 0.01a
CD + E 130.6 ± 11.23a 11.34 ± 1.08 3.53 ± 0.17a 0.31 ± 0.004a
CD + 0.625UD + E 136.4 ± 23.41a 12.56 ± 1.61a 3.81 ± 0.51a 0.31 ± 0.01a
CD + 1.25UD + E 107.33 ± 23.44b 13.14 ± 3.83a 2.16 ± 0.43b 0.34 ± 0.02b
CD +M + E 136 ± 23.27a 10.9 ± 1.54 4.2 ± 0.47a 0.31 ± 0.01a
aIndicates a significant difference with diabetic control
bIndicates a significant difference with negative control, diabetic control, and between-group differences
Table 4 The Serum lipid and lipoprotein results of study groups
Group Cholesterol mg/kg TG mg/kg LDL mg/kg HDL mg/kg
C 83.5 ± 5.71 61.33 ± 10.93a 16.66 ± 11.34 53.43 ± 11.39
C D 89 ± 11.08 118 ± 47.67 14.66 ± 11.69 64.38 ± 20.16
CD + 0.625 UD 89.57 ± 14.15 38.71 ± 12.53a 29.42 ± 22.61 50.15 ± 19.09
CD + 1.25UD 80.14 ± 22.89 58.14 ± 29.12a 22.42 ± 11.78 45.9 ± 10.79
CD +M 83 ± 25.62 51 ± 20.21a 22.6 ± 22.72 49.45 ± 9.07
CD + E 44.6 ± 7.43a 24 ± 1.58b 13.2 ± 6.45 33.12 ± 8.32a
CD + 0.625UD + E 81.4 ± 17.81 34 ± 16.34a 18 ± 16.77 51.42 ± 18.3
CD + 1.25 UD + E 58.83 ± 12.02a 28 ± 9.71b 14.16 ± 11.25 45.06 ± 12.72
CD +M + E 81.6 ± 26.65 57 ± 13.72a 19 ± 14.66 50.5 ± 18.38
aIndicates a significant difference with diabetic control
bIndicates a significant difference with negative control, diabetic control, and between-group differences
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significant differences in the weights of both exercise
groups. Although insulin was increased, pancreatic beta-
cell function had been observed by TG reduction and
increased oxidation of free fatty acids. Nevertheless, pan-
creatic beta-cell function was significantly pronounced
with exercise intensity. In this regard, aerobic capacity
improvement, mitochondrial oxidation, and higher qual-
ity of life for individuals at high risk of diabetes were
more pronounced in the periodic training group than in
the continuous training group [54]. Although this study
was conducted on humans, the results were consistent
with the present study in terms of increase in insulin
sensitivity, beta cell function, TG reduction, and fat
metabolism.
Several studies have proven that moderate intensity
exercise had no desirable effect on blood lipids, glucose,
insulin, and insulin resistance [3, 5] The present study
corroborates these findings. Aerobic activity has no sig-
nificant effect on LDL and HDL but has a significant
effect on blood glucose, cholesterol, TG reduction, insu-
lin resistance, and insulin sensitivity.
A study conducted on diabetic rats by STZ and oral ad-
ministration of aqueous extract of UD concluded that the
aqueous extract of UD could have antihyperlipidemic and
antihyperglycemic effects. Moreover, the aqueous extract
of UD could decrease and increase glycemic markers and
lipid levels [46], similar to the findings of this study. By
contrast, Swanston Flatt showed that UD had no signifi-
cant effect on blood glucose reduction in diabetic mice
[19]. The effect of five natural plant extracts, including
UD, on serum lipoprotein was investigated by Avci et al.
They reported that the administration of UD on rats with
full cholesterol consumption was closely associated
with HDL enhancement and LDL abatement [55].
Furthermore, nettle seeds of Pilulifera reduced blood
sugar and increased the number of Langerhans beta
cells in diabetic rats [30].
The present study showed that the combination of
aerobic exercises along with UD extract consumption
could decrease blood sugar and insulin resistance, in-
crease sensitivity of tissue to insulin, decrease fat serum,
as well as improve the function and proliferation of
Langerhans islets Beta cells, which were more pro-
nounced in the group of UD consumption with swim-
ming activities. As has been reported, UD extract can
form a substance peptide loop (an amino acids chain)
called Gazlin. Experiments conducted in this area have
revealed that the attachment of 10 Gazlin molecules
caused the formation of small tunnels on target tissues
via cell membrane adhesion; this phenomenon made
Fig. 4 Comparison of the effect of UD extracts, swimming exercise and metformin treatment on the islets diameter in normal and diabetic rats;
a: negative control; b: diabetic control; c: diabetic group with UD 0.625 mg/kg treated; d: diabetic group with UD 1.25 g/kg treated; e: diabetic
group with metformin treated; f: diabetic group + exercise; g: diabetic group with 0.625 mg/kg treated + exercise; h: diabetic group with 1.25 g/kg
treated + exercise; i: diabetic group with metformin treated + exercise (haematoxylin and eosin, original magnification × 400)
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glucose to trickle into the cell, thereby reducing blood
sugar [50]. It was also reported that the water extract of
UD increased lipoprotein lipase (LPL) activity [46].
Thus, consumption of UD water extract and sport activ-
ities may decline the severity of diabetes. However, more
studies are warranted to investigate the mechanisms of
this plant.
Conclusion
Use of simultaneous exercises and UD extract consump-
tion can minimize diabetic markers, blood glucose, and
weight gain and can increase insulin sensitivity, cellular
fat metabolism, glucose carriers, insulin receptors in
membrane, pancreatic beta cell proliferation, and glu-
cose uptake stimulation and insulin secretion in vitro.
Although the in vivo data suggested that UD and exer-
cise training could cure diabetic rats, further investiga-
tion is needed to generalize these findings to human
diabetes.
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